Literature DB >> 31002893

GLP-1: Molecular mechanisms and outcomes of a complex signaling system.

Nicholas K Smith1, Troy A Hackett2, Aurelio Galli3, Charles R Flynn4.   

Abstract

Meal ingestion provokes the release of hormones and transmitters, which in turn regulate energy homeostasis and feeding behavior. One such hormone, glucagon-like peptide-1 (GLP-1), has received significant attention in the treatment of obesity and diabetes due to its potent incretin effect. In addition to the peripheral actions of GLP-1, this hormone is able to alter behavior through the modulation of multiple neural circuits. Recent work that focused on elucidating the mechanisms and outcomes of GLP-1 neuromodulation led to the discovery of an impressive array of GLP-1 actions. Here, we summarize the many levels at which the GLP-1 signal adapts to different systems, with the goal being to provide a background against which to guide future research.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  Bariatric surgery; Feeding behavior; Glucagon-like peptide-1; Reward

Mesh:

Substances:

Year:  2019        PMID: 31002893      PMCID: PMC7081944          DOI: 10.1016/j.neuint.2019.04.010

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  217 in total

1.  Direct evidence for the binding of rat liver DPP IV to collagen in vitro.

Authors:  C Hanski; T Huhle; R Gossrau; W Reutter
Journal:  Exp Cell Res       Date:  1988-09       Impact factor: 3.905

2.  Polar transmembrane interactions drive formation of ligand-specific and signal pathway-biased family B G protein-coupled receptor conformations.

Authors:  Denise Wootten; John Simms; Laurence J Miller; Arthur Christopoulos; Patrick M Sexton
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-11       Impact factor: 11.205

3.  Endogenous GLP-1 in lateral septum contributes to stress-induced hypophagia.

Authors:  Sarah J Terrill; Calyn B Maske; Diana L Williams
Journal:  Physiol Behav       Date:  2018-03-03

4.  Intraventricular GLP-1 reduces short- but not long-term food intake or body weight in lean and obese rats.

Authors:  J C Donahey; G van Dijk; S C Woods; R J Seeley
Journal:  Brain Res       Date:  1998-01-01       Impact factor: 3.252

5.  Differential engagement of polar networks in the glucagon-like peptide 1 receptor by endogenous variants of the glucagon-like peptide 1.

Authors:  S G B Furness; A Christopoulos; P M Sexton; D Wootten
Journal:  Biochem Pharmacol       Date:  2018-08-25       Impact factor: 5.858

6.  Human glucagon-like peptides 1 and 2 activate rat brain adenylate cyclase.

Authors:  N M Hoosein; R S Gurd
Journal:  FEBS Lett       Date:  1984-12-03       Impact factor: 4.124

Review 7.  Anti-Obesity Therapy: from Rainbow Pills to Polyagonists.

Authors:  T D Müller; C Clemmensen; B Finan; R D DiMarchi; M H Tschöp
Journal:  Pharmacol Rev       Date:  2018-10       Impact factor: 25.468

8.  Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism.

Authors:  Mary-Elizabeth Patti; Sander M Houten; Antonio C Bianco; Raquel Bernier; P Reed Larsen; Jens J Holst; Michael K Badman; Eleftheria Maratos-Flier; Edward C Mun; Jussi Pihlajamaki; Johan Auwerx; Allison B Goldfine
Journal:  Obesity (Silver Spring)       Date:  2009-04-09       Impact factor: 5.002

9.  GLP-1 analog attenuates cocaine reward.

Authors:  D L Graham; K Erreger; A Galli; G D Stanwood
Journal:  Mol Psychiatry       Date:  2012-10-23       Impact factor: 15.992

10.  Serotonergic modulation of the activity of GLP-1 producing neurons in the nucleus of the solitary tract in mouse.

Authors:  Marie K Holt; Ida J Llewellyn-Smith; Frank Reimann; Fiona M Gribble; Stefan Trapp
Journal:  Mol Metab       Date:  2017-06-07       Impact factor: 7.422

View more
  19 in total

Review 1.  An alternative pathway for sweet sensation: possible mechanisms and physiological relevance.

Authors:  Elena von Molitor; Katja Riedel; Michael Krohn; Rüdiger Rudolf; Mathias Hafner; Tiziana Cesetti
Journal:  Pflugers Arch       Date:  2020-10-08       Impact factor: 3.657

Review 2.  Curbing Obesity from One Generation to Another: the Effects of Bariatric Surgery on the In Utero Environment and Beyond.

Authors:  Redin A Spann; Bernadette E Grayson
Journal:  Reprod Sci       Date:  2020-06-23       Impact factor: 3.060

Review 3.  Signaling pathways in obesity: mechanisms and therapeutic interventions.

Authors:  Xue Wen; Bohan Zhang; Beiyi Wu; Haitao Xiao; Zehua Li; Ruoyu Li; Xuewen Xu; Tao Li
Journal:  Signal Transduct Target Ther       Date:  2022-08-28

Review 4.  Comparing the Efficacy and Safety of Glucagon-Like Peptide 1 Receptor Agonists with Sodium-Glucose Cotransporter 2 Inhibitors for Obese Type 2 Diabetes Patients Uncontrolled on Metformin: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.

Authors:  Lu Ding; Bang Sun; Xinhua Xiao
Journal:  Int J Endocrinol       Date:  2020-09-28       Impact factor: 3.257

Review 5.  Glucagon-Like Peptide-1: A Focus on Neurodegenerative Diseases.

Authors:  Maddalena Grieco; Alessandra Giorgi; Maria Cristina Gentile; Maria d'Erme; Susanna Morano; Bruno Maras; Tiziana Filardi
Journal:  Front Neurosci       Date:  2019-10-18       Impact factor: 4.677

6.  Liraglutide improved the cognitive function of diabetic mice via the receptor of advanced glycation end products down-regulation.

Authors:  Haoqiang Zhang; Yafen Chu; Hongwei Zheng; Jing Wang; Bing Song; Yao Sun
Journal:  Aging (Albany NY)       Date:  2020-11-26       Impact factor: 5.682

Review 7.  Incretin Hormones in Obesity and Related Cardiometabolic Disorders: The Clinical Perspective.

Authors:  Joanna Michałowska; Ewa Miller-Kasprzak; Paweł Bogdański
Journal:  Nutrients       Date:  2021-01-25       Impact factor: 5.717

8.  Exenatide Microspheres for Monthly Controlled-Release Aided by Magnesium Hydroxide.

Authors:  Yuxuan Ge; Zhenhua Hu; Jili Chen; Yujie Qin; Fei Wu; Tuo Jin
Journal:  Pharmaceutics       Date:  2021-05-30       Impact factor: 6.321

Review 9.  Relationships Between Neurodegeneration and Vascular Damage in Diabetic Retinopathy.

Authors:  Maria Grazia Rossino; Massimo Dal Monte; Giovanni Casini
Journal:  Front Neurosci       Date:  2019-11-08       Impact factor: 4.677

10.  Glucagon-like peptide 1 receptor-mediated stimulation of a GABAergic projection from the bed nucleus of the stria terminalis to the hypothalamic paraventricular nucleus.

Authors:  Nadya Povysheva; Huiyuan Zheng; Linda Rinaman
Journal:  Neurobiol Stress       Date:  2021-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.